v3.25.4
Investments in Financial Assets (Details)
€ in Thousands
1 Months Ended 12 Months Ended
Sep. 30, 2023
EUR (€)
May 31, 2021
director
Dec. 31, 2023
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2025
EUR (€)
Dec. 31, 2024
EUR (€)
Oct. 31, 2023
EUR (€)
Disclosure of Investment in Financial Asset and Gain on Disposal of Associate [Line items]              
Fair value loss on investment in financial asset designated as at FVTOCI     € (621)        
Gain (loss) on disposal of associate       € 514      
Yarrow Biotechnology, Inc              
Disclosure of Investment in Financial Asset and Gain on Disposal of Associate [Line items]              
Proportion of ownership interest         3.60%    
Investments in financial assets         € 0   € 0
Kamal Therapeutics, Inc.              
Disclosure of Investment in Financial Asset and Gain on Disposal of Associate [Line items]              
Proportion of ownership interest         0.20% 3.90%  
Investments in financial assets € 0       € 0 € 0  
Fair value loss on investment in financial asset designated as at FVTOCI € (621)            
Gain (loss) on disposal of associate       621      
Yarrow Biotechnology, Inc              
Disclosure of Investment in Financial Asset and Gain on Disposal of Associate [Line items]              
Ownership interest   8.00%          
Number of directors on the board that entity has the right to appoint | director   1          
Total number of directors on the board | director   3          
Wings Therapeutics Inc              
Disclosure of Investment in Financial Asset and Gain on Disposal of Associate [Line items]              
Gain (loss) on disposal of associate       € (107)